Typical, as soon as I subscribe to double my entitlement the price tanks. LOL. I am seriously pissed off at the fact that new institutional shareholders get a better deal than long term shareholders. Perks for those belonging to the inside club. Apparently this is common form for biotechs. Note to self, do not buy biotech shares until they are at stage three and close to FDA approval. Looks like I am stuck in this until 2026.
Typical, as soon as I subscribe to double my entitlement the...
-
- There are more pages in this discussion • 23 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.5¢ |
Change
0.005(1.72%) |
Mkt cap ! $428.5M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 29.8¢ | 29.0¢ | $539.5K | 1.834M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 214062 | 29.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.5¢ | 469318 | 5 |
View Market Depth
| Last trade - 16.10pm 11/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |